Warfarin therapy: INR took between 5 and 8 days after discontinuation to reach 1.2.
|
|
|
Clinical bottom line (level 2b)
-
In patients on warfarin, the international normalised ratio took between 5 and 8 days after warfarin discontinuation to become less than 1.2.
|
|
White et al:
Annals of Internal Medicine
1995;
122 (1):
40-42
|
Expires
June 2003
|
The study
Prospective cohort study
with
?objective ?blinded
outcomes,
not adjusted
for confounding factors,
not
validated in an independent set of patients.
Setting: university medical centre anticoagulation clinic, USA
22 patients
(aged
range 25 to 81 years; mean 55,
55%
male)
patients on warfarin who are considered low risk for thrombosis if they have several days without anticoagulation. Patients were considered low risk if they had:
- deep vein thrombosis after 12 weeks of treatment
- atrial fibrillation with no valvular heart disease, stroke or systemic embolisation
- congestive cardiomyopathy without heart failure, previous stroke or systemic embolisation
Excluded if
complex dosing regimen that precluded simplification
history of widely fluctuating warfarin requirements
Note: Nine patients had atrial fibrillation, ten had venous thromboembolism and three had cardiomyopathy.
Control Group: (n = , analysed):
Experimental Group: (n = , analysed):
Patients received a fixed daily dose of warfarin at 5 pm. After at least a week of this regimen, each patient was seen midday on a Monday (day 1), and his or her international normalised ratio (INR) was measured. Patients then discontinued warfarin therapy and to return on day 3, day 5 and day 8 for repeated INR measurements.
100% followed for
8
days
The evidence
Three days after the last dose of warfarin, 10 out of 22 patients (45%) had an INR greater than 1.5, and 2 out of 22 (9%) had an INR less than 1.2.
On day 5, all but five patients had an INR less than 1.2.
On day 8, 20 patients (91%) had INRs less than 1.2 (one other had an INR of 1.2 and one 1.23).
The mean initial INR was 2.6 mg/d (range 1.95 to 3.8).
Citation
-
White
RH,
McKittrick
T,
Hutchinson
R, et al:
Temporary discontinuation of warfarin therapy: Changes in the international normalized ratio.
Annals of Internal Medicine
1995;
122 (1):
40-42
Contributor: Clare Wotton and Musab Hayatli,
June 2000
Reviewer: Martin Dawes
Clinical Question.
| Patient |
on warfarin and low risk for thrombosis |
| Intervention or Exposure |
discontinuation of warfarin |
| Outcome |
international normalised ratio |
|
|